收藏切换
The efficacy of Xinkang capsules in the adjuvant treatment ofcoronary atherosclerotic heart disease stable angina pectoris with Qi and Yin deficiency and blood stasis syndrome
收藏切换
Yongfu WANG1, Qiang LI1, Dongyan PENG1, Xiaona DU2, *, Meihua XIA3
World Clinical Drug | 2025, 46(6) : 599 - 605
Less
收藏切换
World Clinical Drug | 2025, 46(6): 599-605
• Article •
The efficacy of Xinkang capsules in the adjuvant treatment ofcoronary atherosclerotic heart disease stable angina pectoris with Qi and Yin deficiency and blood stasis syndrome
Full
Yongfu WANG1, Qiang LI1, Dongyan PENG1, Xiaona DU2, *, Meihua XIA3
Affiliations
  • 1.Department of Pharmacy, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
  • 2.Department of Laboratory, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
  • 3.Department of Cardiology, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
Published: 2025-06-10 doi: 10.13683/j.wph.2025.06.011
Outline
收藏切换
Objective

To explore the effect of Xinkang capsules in patients with stable angina pectoris(SAP) of coronary atherosclerotic heart disease(CHD).

Methods

A total of 106 CHD-SAP patients with Qi and Yin deficiency and blood stasis syndrome admitted to our hospital from February 2023 to January 2025 were randomly divided into the control group(treated with conventional western medicine) and the combined group(combined with Xinkang capsules) by simple sorting random method, with 53 cases in each group. Both groups were treated for 8 weeks. The clinical efficacy, efficacy of traditional Chinese medicine(TCM) syndromes, angina pectoris attacks, hemorheological indicators, inflammatory response indicators[nucleotide-binding oligomerization domain-like receptor protein(NLRP)3, interleukin(IL)-18,monocyte chemotactic protein(MCP)-1], cardiac function [cardiac output(CO), left ventricular ejection fraction(LVEF),left ventricular end diastolic diameter(LVEDD), and adverse reactions after treatment were compared between the two groups.

Results

The total effective rate and the therapeutic effect of TCM syndromes in the combined group were both higher than those in the control group(P<0.05). The duration and frequency of angina pectoris attacks, high shear viscosity of whole blood, low shear viscosity of whole blood, plasma viscosity and erythrocyte aggregation index in the combined group were all lower than those in the control group(P<0.05). The levels of NLRP3, IL-18 and MCP-1 in the combined group were lower than those in the control group(P<0.05). The improvement of CO, LVEF and LVEDD in the combined group was better than that in the control group(P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups during the treatment period(P>0.05).

Conclusion

The adjuvant therapy of Xinkang capsules can improve the clinical efficacy of CHD-SAP patients with Qi and Yin deficiency and blood stasis, effectively relieve the attack of angina pectoris, reduce the inflammatory response, improve hemorheology and cardiac function, and has a relatively high safety.

coronary atherosclerotic heart disease  /  stable angina pectoris  /  Xinkang capsule  /  blood rheology  /  cardiac function
王永伏, 李强, 彭冬雁, 杜晓娜, 夏梅华. 欣康胶囊辅助治疗气阴两虚兼血瘀证冠状动脉粥样硬化性心脏病稳定型心绞痛效果. 世界临床药物, 2025 , 46 (6) : 599 -605 . DOI: 10.13683/j.wph.2025.06.011
Yongfu WANG, Qiang LI, Dongyan PENG, Xiaona DU, Meihua XIA. The efficacy of Xinkang capsules in the adjuvant treatment ofcoronary atherosclerotic heart disease stable angina pectoris with Qi and Yin deficiency and blood stasis syndrome[J]. World Clinical Drug, 2025 , 46 (6) : 599 -605 . DOI: 10.13683/j.wph.2025.06.011
Year 2025 volume 46 Issue 6
49
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.06.011
  • Receive Date:2025-02-15
  • Online Date:2026-11-09
  • Published:2025-06-10
Article Data
Affiliations
History
  • Received:2025-02-15
Affiliations
    1.Department of Pharmacy, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
    2.Department of Laboratory, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
    3.Department of Cardiology, Hengshui Hospital of Traditional Chinese Medicine, Hengshui 053000, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.06.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT